Corpus 1,283 assessed · 1,184 scored · 647 reproduced ≥75 · 173 flagged ·∅ 73.9/100

Publications 2 Datasets 392.5k Experiments 5.3k

Explore

Filters: 2023 ✕ 0 ✕ other ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. PMID 37231145	NPJ Precis Oncol	2023	40	L1 40/100
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells. PMID 37081150	Nat Immunol	2023	37	L1 37/100

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.

PMID 37231145 · NPJ Precis Oncol · 2023

L1 40/100

Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.

PMID 37081150 · Nat Immunol · 2023

L1 37/100